Sunshine Biopharma (SBFM.OTC) stock price, revenue, and financials

Sunshine Biopharma annual revenue was $447.20 k in FY 2018

$3 K

Sunshine Biopharma Revenue Q2, 2019
Sunshine Biopharma Gross profit (Q2, 2019)1.6 K
Sunshine Biopharma Gross profit margin (Q2, 2019), %51.9%
Sunshine Biopharma Net income (Q2, 2019)-710.9 K
Sunshine Biopharma EBIT (Q2, 2019)-66.2 K
Sunshine Biopharma Cash, 30-Jun-201937.3 K
Sunshine Biopharma EV12.4 M

Sunshine Biopharma Income Statement

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.7k447.2k

Cost of goods sold

391.1k

Gross profit

56.1k

Gross profit Margin, %

13%

R&D expense

137.4k8.7k32.8k

Operating expense total

137.4k8.7k32.8k

Depreciation and amortization

4.3k60.7k

EBIT

(1.2m)

EBIT margin, %

(261%)

Interest expense

6.5k307.2k34.7k104.8k159.4k

Net Income

(2.5m)(1.7m)(3.5m)(1.0m)(2.2m)

Quarterly

USDQ2, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

3.0k

Cost of goods sold

91.6k102.8k84.9k1.5k

Gross profit

1.6k

Gross profit Margin, %

52%

R&D expense

323.0k8.7k32.8k

Operating expense total

323.0k8.7k32.8k

Depreciation and amortization

4.9k6.7k602.0602.0579.03.4k

EBIT

(120.8k)(66.2k)

EBIT margin, %

(2183%)

Interest expense

52.9k33.2k9.8k7.0k10.0k12.1k9.1k9.6k27.4k75.5k28.4k24.3k49.8k18.3k

Net Income

(818.4k)(517.5k)(202.8k)(305.3k)(392.3k)(1.6m)(195.7k)(485.4k)(147.6k)(265.6k)(644.3k)(907.6k)(202.5k)(710.9k)

Sunshine Biopharma Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

31.2k143.4k50.8k57.5k107.5k115.2k

Accounts Receivable

95.0k

Current Assets

31.2k143.4k53.9k58.5k117.2k211.5k

Total Assets

31.2k143.4k673.3k64.4k257.5k1.1m

Accounts Payable

23.8k34.8k46.6k28.1k19.3k191.1k

Short-term debt

12.5k480.1k305.2k69.9k516.9k419.7k

Total Debt

12.5k305.2k69.9k516.9k419.7k

Total Liabilities

39.0k1.3m274.1k830.8k1.2m

Total Equity

(7.7k)(387.6k)(597.0k)(209.7k)

Debt to Equity Ratio

-0.3 x

Debt to Assets Ratio

1.1 x

Financial Leverage

-4.1 x-0.4 x-1.1 x-0.3 x

Sunshine Biopharma Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(1.7m)

Depreciation and Amortization

4.3k

Accounts Payable

23.2k11.0k11.8k(19.0k)(8.8k)61.6k

Interest Paid

5.3k21.9k23.5k

Income Taxes Paid

Quarterly

USDQ3, 2013Q2, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(681.1k)(828.8k)(265.6k)(909.9k)(1.8m)

Depreciation and Amortization

15.2k30.2k45.2k525.01.0k4.9k6.7k16.4k43.3k16.5k6.8k

Accounts Receivable

(12.9k)(28.7k)(23.4k)(24.2k)(1.0k)

Accounts Payable

8.2k70.1k901.0(129.0)(52.1k)

Purchases of PP&E

(2.3k)(2.3k)(22.3k)(4.8k)(27.4k)(27.4k)(485.0)

Cash From Investing Activities

(22.4k)(22.4k)

Interest Paid

3.5k9.4k13.6k13.6k11.0k11.0k

Sunshine Biopharma Ratios

USDY, 2019

EV/EBIT

-186.6 x

Financial Leverage

-0.1 x